Source: GlobeNewswire

Press Release: Alkahest : Alkahest Provides Corporate Update

SAN CARLOS, Calif., July 09, 2020 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical stage biotechnology company focused on discovering and developing transformative therapies to treat age-related diseases, today provided a corporate update.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Karoly Nikolich's photo - Chairman & CEO of Alkahest

Chairman & CEO

Karoly Nikolich

CEO Approval Rating

86/100

Read more